Publications

1. Miwa T, Hsu CL, Shimizu M, Bloom PP, Schnabl B. Covert hepatic encephalopathy as a multi-organ syndrome: the gut-liver-muscle-brain axis, diagnosis, treatment, and multidisciplinary care. J Gastroenterol. 2026 Sep; 61 (9):1217-1233 Epub 2026 May 08
   View PubMed
2. Khanna S, Bloom PP. Difficile to treat: advanced management strategies in difficult to treat Clostridioides difficile infections. Expert Rev Anti Infect Ther. 2026 Apr; 24 (4):413-424 Epub 2026 Apr 15
   View PubMed
3. Bloom P, Khanna S. Fecal microbiota transplantation in chronic liver disease: Current and future state of the art. Hepatol Commun. 2026 Apr 1; 10 (4) Epub 2026 Mar 20
   View PubMed
4. Bloom PP, Tapper EB, Asrani SK, Lok AS. Animal Naming Test Predicts Future Overt Hepatic Encephalopathy. Clin Gastroenterol Hepatol. 2026 Jan 10 [Epub ahead of print]
   View PubMed
5. Bloom PP, Garrett WS, Penniston KL, Winkler MH, Hazen SL, Agudelo J, Suryavanshi M, Babiker A, Dodd D, Fischbach MA, Huang KC, Huttenhower C, Joe B, Kalantar-Zadeh K, Knight R, Miller AW, Rabb H, Srivastava A, Tang WHW, Turnbaugh PJ, Walker AW, Wilck N, Xu J, Yang T, Himmelfarb J, Redinbo MR, Wu GD, Woodworth MH, Ackerman AL, Winter S, Rinschen MM, Hassan HA, Biruete A, Anderson AH, Pluznick JL. Microbiota and kidney disease: the road ahead. Nat Rev Nephrol. 2025 Oct; 21 (10):702-716 Epub 2025 July 28
   View PubMed
6. Bloom PP, Fisher CJ, Tedesco N, Kamdar N, Garrido-Trevino L, Robin J, Asrani SK, Lok AS. HEAR-MHE study: Automated speech analysis identifies minimal hepatic encephalopathy and may predict future overt hepatic encephalopathy. Hepatology. 2025 Jun 1; 81 (6):1740-1752 Epub 2024 Sept 12
   View PubMed
7. Bloom PP, Bassis CM, Crossette E, Silber JL, Norman JM, Young VB, Lok ASF. Safety and efficacy of a defined bacterial consortium, VE303, to treat HE. Hepatol Commun. 2025 Mar 1; 9 (3) Epub 2025 Feb 19
   View PubMed
8. Tapper EB, Nikirk S, Evon DM, Asrani S, Bloom P, Hynes JW, Alber JM, Gill A, Mehta S, Weinberg E, Alexander NB, Althuis K, Hoelscher A, Zhao L, Chen X, Burdzy A, Serper M. LIVE-SMART: A sequential, multiple assignment randomized trial to reduce falls in cirrhosis. Hepatol Commun. 2025 Mar 1; 9 (3) Epub 2025 Feb 19
   View PubMed
9. Bloom PP. A new gut-brain therapeutic target for hepatic encephalopathy. Nat Med. 2025 Feb; 31 (2):386-387
   View PubMed
10. Bloom PP. The Misdiagnosis and Underdiagnosis of Hepatic Encephalopathy. Clin Transl Gastroenterol. 2025 Feb 1; 16 (2):e00784 Epub 2025 Feb 01
    View PubMed
11. Rice G, Douville N, Kumar S, Bloom P. Optimizing Anesthesia Management in Liver Transplantation With Use of Real Time Frontal Electroencephalogram. Clin Transplant. 2025 Feb; 39 (2):e70110
    View PubMed
12. Bloom PP, Chung RT. The future of clinical trials of gut microbiome therapeutics in cirrhosis. JHEP Rep. 2025 Jan; 7 (1):101234 Epub 2024 Oct 10
    View PubMed
13. Kaplan A, Aby ES, Scott S, Sonnenday C, Fox A, Mathur A, Olthoff K, Heimbach J, Ladin K, Emamaullee J, NALLDIG Consortium. Financial toxicity in living donor liver transplantation: A call to action for financial neutrality. Am J Transplant. 2024 Oct; 24(10):1742-1754. Epub 2024 May 18.
    View PubMed
14. Gairing SJ, Mangini C, Zarantonello L, Jonasson E, Dobbermann H, Sultanik P, Galle PR, Labenz J, Thabut D, Marquardt JU, Bloom PP, Lauridsen MM, Montagnese S, Labenz C. Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study. JHEP Rep. 2024 Aug; 6 (8):101104 Epub 2024 Apr 26
    View PubMed
15. Gairing SJ, Mangini C, Zarantonello L, Jonasson E, Danneberg S, Sultanik P, Galle PR, Gioia S, Labenz J, Lok AS, Marquardt JU, Lauridsen MM, Bloom PP, Thabut D, Nardelli S, Montagnese S, Labenz C. PHES scores have limited impact on the risk of overt HE in patients with minimal HE. Hepatol Commun. 2024 May 1; 8 (5) Epub 2024 May 03
    View PubMed
16. Gairing SJ, Mangini C, Zarantonello L, Gioia S, Nielsen EJ, Danneberg S, Lok AS, Sultanik P, Galle PR, Labenz J, Thabut D, Marquardt JU, Bloom PP, Lauridsen MM, Montagnese S, Nardelli S, Labenz C. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival. J Intern Med. 2024 Mar; 295 (3):331-345 Epub 2023 Nov 20
    View PubMed
17. Bloom PP, Che Z, Hyde A, Johnson E, Miguel-Cruz A, Carbonneau M, Hazra D, Tandon P. Development and Evaluation of a Patient Cirrhosis Knowledge Assessment. Dig Dis Sci. 2024 Feb; 69 (2):399-409 Epub 2024 Jan 03
    View PubMed
18. Bloom PP, Bajaj JS. The Current and Future State of Microbiome Therapeutics in Liver Disease. Am J Gastroenterol. 2024 Jan 1; 119 (1S):S36-S41
    View PubMed
19. Gairing SJ, Mangini C, Zarantonello L, Gioia S, Nielsen EJ, Danneberg S, Gabriel M, Ehrenbauer AF, Bloom PP, Ripoll C, Sultanik P, Galle PR, Labenz J, Thabut D, Zipprich A, Lok AS, Weissenborn K, Marquardt JU, Lauridsen MM, Nardelli S, Montagnese S, Labenz C. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study. Am J Gastroenterol. 2023 Dec 1; 118 (12):2191-2200 Epub 2023 Mar 20
    View PubMed
20. Bloom PP, Tapper EB. Lactulose in cirrhosis: Current understanding of efficacy, mechanism, and practical considerations. Hepatol Commun. 2023 Nov 1; 7 (11) Epub 2023 Oct 12
    View PubMed
21. Bloom PP, Rao K, Bassis C, Nojkov B, Young VB, Lok AS. Regional changes in intestinal permeability in cirrhosis are associated with mucosal bacteria. Hepatol Commun. 2023 Oct 1; 7 (10) Epub 2023 Sept 27
    View PubMed
22. Bloom PP, Gilbert T, Santos-Parker K, Memel Z, Przybyszewski E, Bethea E, Sonnenday CJ, Tapper EB, Waits S. The incidence and natural history of ascites after liver transplantation. Hepatol Commun. 2023 Jun 1; 7 (6) Epub 2023 May 23
    View PubMed
23. Aby ES, Moafa G, Latt N, Sultan MT, Cacioppo PA, Kumar S, Chung RT, Bloom PP, Gustafson J, Daidone M, Reinus Z, Debes JD, Sandhu S, Sohal A, Khalid S, Roytman M, Catana AM, Wegermann K, Carr RM, Saiman Y, Kassab I, Chen VL, Rabiee A, Rosenberg C, Nguyen V, Gainey C, Zhou K, Chavin K, Lizaola-Mayo BC, Chascsa DM, Varelas L, Moghe A, Dhanasekaran R. Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Hepatol Commun. 2023 Jan 01; 7(1):e8874. Epub 2023 Jan 03.
    View PubMed
24. Levine JW, Hawa F, Bloom PP. Incidental Hepatocellular Carcinoma Bony Metastasis in a Patient Listed for Liver Transplant. ACG Case Rep J. 2023 Jan; 10 (1):e00967 Epub 2023 Jan 27
    View PubMed
25. Bloom PP, Young VB. Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection. Expert Opin Biol Ther. 2023 Jan; 23 (1):89-101 Epub 2022 Dec 19
    View PubMed
26. Bloom PP, Rao K, Bassis CM, Zhou SY, Nojkov B, Owyang C, Young VB, Lok AS. Duodenal Permeability Is Associated With Mucosal Microbiota in Compensated Cirrhosis. Clin Transl Gastroenterol. 2022 Oct 1; 13 (10):e00522 Epub 2022 Oct 01
    View PubMed
27. Bloom PP, Donlan J, Torres Soto M, Daidone M, Hohmann E, Chung RT. Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient. Hepatol Commun. 2022 Aug; 6 (8):2079-2089 Epub 2022 Apr 05
    View PubMed
28. Bloom PP, Ventoso M, Tapper E, Ha J, Richter JM. A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving. Dig Dis Sci. 2022 Mar; 67 (3):854-862 Epub 2021 May 06
    View PubMed
29. Memel ZN, Lee JJ, Foulkes AS, Chung RT, Thaweethai T, Bloom PP. Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2022 Jan 5; 225 (1):19-29
    View PubMed
30. Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2022 Jan; 20(1):183-193. Epub 2020 Sep 12.
    View PubMed
31. DiGiacomo DV, Shay JE, Crotty R, Yang N, Bloom P, Corey K, Barmettler S, Farmer JR. Liver Stiffness by Transient Elastography Correlates With Degree of Portal Hypertension in Common Variable Immunodeficiency Patients With Nodular Regenerative Hyperplasia. Front Immunol. 2022; 13:864550 Epub 2022 May 06
    View PubMed
32. Song Z, Kannan S, Gambrel RJ, Marino M, Vaduganathan M, Clapp MA, Seiglie JA, Bloom PP, Malik AN, Resnick MJ. Physician Practice Pattern Variations in Common Clinical Scenarios Within 5 US Metropolitan Areas. JAMA Health Forum. 2022 Jan; 3 (1):e214698 Epub 2022 Jan 28
    View PubMed
33. Bloom PP, Tapper EB, Young VB, Lok AS. Microbiome therapeutics for hepatic encephalopathy. J Hepatol. 2021 Dec; 75 (6):1452-1464 Epub 2021 Aug 25
    View PubMed
34. Bloom PP, Luevano JM Jr, Miller KJ, Chung RT. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy. Ann Hepatol. 2021 Nov-Dec; 25:100333 Epub 2021 Feb 20
    View PubMed
35. Bloom PP, Robin J, Xu M, Arvind A, Daidone M, Gupta AS, Chung RT. Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment. Am J Gastroenterol. 2021 Sep 1; 116 (9):1950-1953
    View PubMed
36. Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen VL, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin KD, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch AD, Viveiros K, Chan W, Chascsa DM, Kwo P, Dhanasekaran R. Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2021 Jul; 19(7):1469-1479.e19. Epub 2020 Sep 17.
    View PubMed
37. Bloom PP, Venkatesh RD, Dellon ES, Chang JW. Making Social Media Work for You. Dig Dis Sci. 2021 Jul; 66 (7):2149-2153 Epub 2021 Apr 28
    View PubMed
38. Bloom PP, Pasricha TS, Andersson KL, Pratt DS, Hashemi N, Bhan I, Viveiros K. Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management. Dig Dis Sci. 2021 Jun; 66 (6):1852-1854 Epub 2020 July 29
    View PubMed
39. Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT. Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology. 2021 Mar; 73 (3):890-900 Epub 2020 Nov 04
    View PubMed
40. Saleh ZM, Bloom PP, Grzyb K, Tapper EB. How Do Patients With Cirrhosis and Their Caregivers Learn About and Manage Their Health? A Review and Qualitative Study. Hepatol Commun. 2021 Feb; 5 (2):168-176 Epub 2020 Nov 17
    View PubMed
41. Rabiee A, Sadowski B, Adeniji N, Perumalswami PV, Nguyen V, Moghe A, Latt NL, Kumar S, Aloman C, Catana AM, Bloom PP, Chavin KD, Carr RM, Dunn W, Chen VL, Aby ES, Debes JD, Dhanasekaran R, COLD Consortium. Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience. Hepatology. 2020 Dec; 72 (6):1900-1911 Epub 2020 Dec 09
    View PubMed
42. Bloom PP, Tapper EB. The Use of Administrative Data to Investigate the Population Burden of Hepatic Encephalopathy. J Clin Med. 2020 Nov 10; 9 (11)
    View PubMed
43. Bloom PP, Miller SJ, Nayak RK, Hussain MS, Arvind A, Bay C, Chung RT. Cognitive Tests and Stool Frequency at Hospital Discharge Do Not Predict Outcomes in Hepatic Encephalopathy. South Med J. 2020 Nov; 113 (11):578-584
    View PubMed
44. Bloom P, Wang T, Marx M, Tagerman M, Green B, Arvind A, Ha J, Bloom J, Richter JM. A Smartphone App to Manage Cirrhotic Ascites Among Outpatients: Feasibility Study. JMIR Med Inform. 2020 Sep 2; 8 (9):e17770 Epub 2020 Sept 02
    View PubMed
45. Bloom PP. A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic. Dig Dis Sci. 2020 Jun; 65 (6):1557-1558
    View PubMed
46. Bethea E, Arvind A, Gustafson J, Andersson K, Pratt D, Bhan I, Thiim M, Corey K, Bloom P, Markmann J, Yeh H, Elias N, Kimura S, Dageforde LA, Cuenca A, Kawai T, Safa K, Williams W, Gilligan H, Sise M, Fishman J, Kotton C, Kim A, Rogers CC, Shao S, Cote M, Irwin L, Myoung P, Chung RT. Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning. Am J Transplant. 2020 Jun; 20 (6):1619-1628 Epub 2020 Feb 03
    View PubMed
47. Schaefer EAK, Arvind A, Bloom PP, Chung RT. Interrelationship Between Coronavirus Infection and Liver Disease. Clin Liver Dis (Hoboken). 2020 May; 15 (5):175-180 Epub 2020 May 21
    View PubMed
48. Bajaj JS, Bloom PP, Chung RT, Hassanein TI, Padilla-Martinez M, Kayali Z, Rockey DC, Sasso R, Muthukumar AR, Lee WM, Denney WS, Gavis EA, Anderson C, Blankstein L, Brennan AM, Puurunen MK, Lawitz E. Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice. Am J Gastroenterol. 2020 May; 115 (5):783-785
    View PubMed
49. Bloom PP, Rodriguez-Lopez J, Witkin AS, Al-Samkari H, Kuter DJ, Mojtahed A, Luther J. Ammonia Predicts Hepatic Involvement and Pulmonary Hypertension in Patients With Hereditary Hemorrhagic Telangiectasia. Clin Transl Gastroenterol. 2020 Jan; 11 (1):e00118
    View PubMed
50. Bloom PP, Mojtahed A, Bethea ED, Knooihuizen SA, Choi J, Dienstag JL, Chung RT, Hur C. Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes. Dig Dis Sci. 2020 Jan; 65 (1):312-321 Epub 2019 July 30
    View PubMed
51. Bloom PP. Attitudes towards digital health tools for outpatient cirrhosismanagement in patients with decompensated cirrhosis BMJ. 2020.
    
52. DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH, Turbett S, Chung RT, Chen YB, Hohmann EL. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med. 2019 Nov 21; 381 (21):2043-2050 Epub 2019 Oct 30
    View PubMed
53. Pringle PL, Soto MT, Chung RT, Hohmann E. Patients With Cirrhosis Require More Fecal Microbiota Capsules to Cure Refractory and Recurrent Clostridium difficile Infections. Clin Gastroenterol Hepatol. 2019 Mar; 17 (4):791-793 Epub 2018 May 31
    View PubMed
54. Pringle PL, Stewart KO, Peloquin JM, Sturgeon HC, Nguyen D, Sauk J, Garber JJ, Yajnik V, Ananthakrishnan AN, Chan AT, Xavier RJ, Khalili H. Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. Inflamm Bowel Dis. 2015 Oct; 21 (10):2304-2310
    View PubMed
55. Collins CE, Pringle PL, Santry HP. Innovation or rebranding, acute care surgery diffusion will continue. J Surg Res. 2015 Aug; 197 (2):354-62 Epub 2015 Mar 23
    View PubMed
56. Santry HP, Pringle PL, Collins CE, Kiefe CI. A qualitative analysis of acute care surgery in the United States: it's more than just "a competent surgeon with a sharp knife and a willing attitude". Surgery. 2014 May; 155 (5):809-25 Epub 2013 Dec 16
    View PubMed
57. Pringle PL, Collins C, Santry HP. Utilization of morning report by acute care surgery teams: results from a qualitative study. Am J Surg. 2013 Nov; 206 (5):647-54
    View PubMed
58. Bogdan R, Pringle P, Goetz E, Pizzagalli D. Perceived Stress, Anhedonia and Illusion of Control: Evidence for Two Mediational Models. Cognit Ther Res. 2012 Dec 1; 36 (6):827-832
    View PubMed